A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma
NCT05294120 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 38
Last updated 2026-04-20
Summary
The purpose of this study is to find out if radiation therapy (RT) guided by the new reflectance confocal microscopy (RCM)/optical coherence tomography (OCT) device is an effective treatment for basal cell carcinoma (BCC). The researchers will also look at the side effects from RT guided by the RCM/OCT device. In addition, will determine the quality of life before and after treatment by having the participant fill out questionnaires.
Conditions
Interventions
- DEVICE
-
Reflectance ConfocaL Microscopy And Optical Coherence Tomography Guided
Patients will undergo RCM/OCT with an imaging specialist in the Dermatology Service. This is not expected to take longer than 30 minutes. Prior to imaging, a digital photograph will be taken of the biopsy proven BCC.
- RADIATION
-
Radiation Therapy
After the completion of skin imaging, patients will undergo simulation and tumor radiotherapy. An equivalent total dose in 2 Gy fractions (EQD2) of 45-46 Gy will be delivered for treatment.
Sponsors & Collaborators
-
Physical Sciences Inc.
collaborator UNKNOWN -
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Christopher Barker, MD · Memorial Sloan Kettering Cancer Center
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-03
- Primary Completion
- 2027-03-31
- Completion
- 2027-03-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Head and Neck Cancer
NCT02923570 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Individualized Stereotactic Body Radiotherapy of Liver Metastases
NCT01239381 ·Status: COMPLETED ·Phase: NA
-
Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect
NCT03825510 ·Status: COMPLETED ·Phase: PHASE2
-
Electronic Brachytherapy for the Treatment of NMSC
NCT01016899 ·Status: COMPLETED
-
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors
NCT03721341 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Stereotactic Body Radiation With Nelfinavir for Oligometastases
NCT01728779 ·Status: COMPLETED ·Phase: PHASE2
-
Margin-Based Vs. Robust Photon Radiotherapy Planning in IMRT of HN-SQCC
NCT03552965 ·Status: COMPLETED ·Phase: NA
-
SBRT for Extra-cranial Oligorecurrent Tumor
NCT02410187 ·Status: UNKNOWN ·Phase: PHASE2
-
Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer
NCT01576939 ·Status: COMPLETED ·Phase: NA
-
Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Metastatic Tumors to the Liver
NCT01030757 ·Status: TERMINATED ·Phase: PHASE2
-
Monitoring Chemotherapy Response of Soft Tissue Sarcomas and Osteosarcomas Using Diffuse Optical Spectroscopic Imaging
NCT01263405 ·Status: COMPLETED
-
Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery
NCT05943119 ·Status: RECRUITING ·Phase: PHASE2
-
Novel Lung Functional Imaging for Personalized Radiotherapy
NCT02308709 ·Status: COMPLETED ·Phase: NA
-
MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer
NCT02582931 ·Status: COMPLETED ·Phase: PHASE1
-
Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases
NCT03391362 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
NCT06910761 ·Status: RECRUITING ·Phase: PHASE2
-
Stereotactic Body Radiation Therapy (SBRT) as a Boost After Definitive Concurrent Chemoradiation (ChemoRT) for Non-Small Cell Lung Cancer (NSCLC) GCC 0516
NCT00818714 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Phase I/II Trial of Stereotactic Body Radiation Therapy
NCT00591838 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases
NCT02159742 ·Status: ACTIVE_NOT_RECRUITING
-
Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma
NCT06014827 ·Status: RECRUITING ·Phase: PHASE2
-
Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma
NCT04974671 ·Status: RECRUITING ·Phase: PHASE2
-
Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry
NCT03716193 ·Status: TERMINATED ·Phase: NA
-
Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck Cancer
NCT01011842 ·Status: TERMINATED ·Phase: NA
-
Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases
NCT02181829 ·Status: COMPLETED ·Phase: PHASE2
-
Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)
NCT02722395 ·Status: COMPLETED